As of 2025-10-17, the Relative Valuation of XBiotech Inc (XBIT) is (7.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.49 USD, the upside of XBiotech Inc based on Relative Valuation is -416.2%.
The range of the Relative Valuation is (6.24) - (10.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.2x | 7.8x |
| Forward P/E multiples | 6.8x - 11.7x | 9.2x |
| Fair Price | (6.24) - (10.36) | (7.87) |
| Upside | -350.8% - -516.2% | -416.2% |
| Date | P/E |
| 2025-10-16 | -2.70 |
| 2025-10-15 | -2.75 |
| 2025-10-14 | -2.72 |
| 2025-10-13 | -2.77 |
| 2025-10-10 | -2.75 |
| 2025-10-09 | -2.81 |
| 2025-10-08 | -2.91 |
| 2025-10-07 | -2.86 |
| 2025-10-06 | -2.88 |
| 2025-10-03 | -2.86 |
| 2025-10-02 | -2.86 |
| 2025-10-01 | -2.86 |
| 2025-09-30 | -2.88 |
| 2025-09-29 | -2.91 |
| 2025-09-26 | -2.92 |
| 2025-09-25 | -2.91 |
| 2025-09-24 | -3.01 |
| 2025-09-23 | -3.15 |
| 2025-09-22 | -2.98 |
| 2025-09-19 | -2.94 |
| 2025-09-18 | -2.99 |
| 2025-09-17 | -2.89 |
| 2025-09-16 | -2.91 |
| 2025-09-15 | -2.94 |
| 2025-09-12 | -2.98 |
| 2025-09-11 | -3.05 |
| 2025-09-10 | -3.03 |
| 2025-09-09 | -3.02 |
| 2025-09-08 | -2.97 |
| 2025-09-05 | -3.16 |
| 2025-09-04 | -3.23 |
| 2025-09-03 | -3.23 |
| 2025-09-02 | -3.27 |
| 2025-08-29 | -3.42 |
| 2025-08-28 | -3.67 |
| 2025-08-27 | -3.77 |
| 2025-08-26 | -3.79 |
| 2025-08-25 | -3.46 |
| 2025-08-22 | -3.46 |
| 2025-08-21 | -3.46 |
| 2025-08-20 | -3.49 |
| 2025-08-19 | -3.48 |
| 2025-08-18 | -3.46 |
| 2025-08-15 | -3.41 |
| 2025-08-14 | -3.51 |
| 2025-08-13 | -3.40 |
| 2025-08-12 | -3.22 |
| 2025-08-11 | -3.19 |
| 2025-08-08 | -3.16 |
| 2025-08-07 | -3.16 |